Rebecca Zeuren1, Agnese Biagini1, Ravinder K Grewal2, Gregory W Randolph3,4, Dipti Kamani3, Mona M Sabra1, Ashok R Shaha1,5, R Michael Tuttle1. 1. Department of Endocrinology Service, Memorial Sloan-Kettering Cancer Center, New York, New York. 2. Department of Nuclear Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. 3. Division of Thyroid and Parathyroid Surgery, Otolaryngology, Massachusetts Eye and Ear Infirmary. 4. Department of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A. 5. Department of Head and Neck Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
Abstract
OBJECTIVE: Recent, more selective use of radioactive iodine (RAI) has led to reevaluation of the clinical importance of achieving complete total thyroidectomy with minimal residual normal thyroid tissue. We utilize the improved localization by post-RAI remnant ablation, single photon emission computerized tomography-computed tomography (SPECT-CT) to define specific anatomic sites of residual RAI-uptake foci after total thyroidectomy for differentiated thyroid cancer (DTC) and to provide a novel classification system relating uptake to thyroid anatomy and preservation of adjacent neural structures. STUDY DESIGN: Retrospective. METHOD: Radioactive iodine-uptake foci in thyroid bed were localized by SPECT/CT imaging at the time of RAI remnant ablation in 141 DTC patients undergoing total thyroidectomy. RESULTS: Minimal residual RAI uptake (median 0.32% at 24 hours) in the thyroid bed was detected by diagnostic planar whole body scans in 93% and by posttherapy SPECT/CT imaging in 99% of subjects. Discrete RAI uptake foci were identified on the SPECT/CT imaging at Berry's ligament (87%), at superior thyroid poles (79%), in paratracheal-lobar regions (67%), in isthmus-region (54%), and in pyramidal lobe (46%). Despite the residual foci, the nonstimulated thyroglobulin (Tg) prior to remnant ablation (with a median thyroid-stimulating hormone of 0.36 m IU/L) was < 0.6 ng/mL in 53% and < 1 ng/mL in 73% of cases. CONCLUSION: After extracapsular total thyroidectomy, highly sensitive detection tools identify microscopic residual RAI avid foci in thyroid bed in the majority of patients. These foci can be classified as 1) neural-related and 2) capsule-related. These common residual foci have no relationship to postoperative Tg, suggesting that attempts at radical removal of thyroid tissue in these locations may not be warranted. LEVEL OF EVIDENCE: 4.
OBJECTIVE: Recent, more selective use of radioactive iodine (RAI) has led to reevaluation of the clinical importance of achieving complete total thyroidectomy with minimal residual normal thyroid tissue. We utilize the improved localization by post-RAI remnant ablation, single photon emission computerized tomography-computed tomography (SPECT-CT) to define specific anatomic sites of residual RAI-uptake foci after total thyroidectomy for differentiated thyroid cancer (DTC) and to provide a novel classification system relating uptake to thyroid anatomy and preservation of adjacent neural structures. STUDY DESIGN: Retrospective. METHOD:Radioactive iodine-uptake foci in thyroid bed were localized by SPECT/CT imaging at the time of RAI remnant ablation in 141 DTC patients undergoing total thyroidectomy. RESULTS: Minimal residual RAI uptake (median 0.32% at 24 hours) in the thyroid bed was detected by diagnostic planar whole body scans in 93% and by posttherapy SPECT/CT imaging in 99% of subjects. Discrete RAI uptake foci were identified on the SPECT/CT imaging at Berry's ligament (87%), at superior thyroid poles (79%), in paratracheal-lobar regions (67%), in isthmus-region (54%), and in pyramidal lobe (46%). Despite the residual foci, the nonstimulated thyroglobulin (Tg) prior to remnant ablation (with a median thyroid-stimulating hormone of 0.36 m IU/L) was < 0.6 ng/mL in 53% and < 1 ng/mL in 73% of cases. CONCLUSION: After extracapsular total thyroidectomy, highly sensitive detection tools identify microscopic residual RAI avid foci in thyroid bed in the majority of patients. These foci can be classified as 1) neural-related and 2) capsule-related. These common residual foci have no relationship to postoperative Tg, suggesting that attempts at radical removal of thyroid tissue in these locations may not be warranted. LEVEL OF EVIDENCE: 4.
Authors: Hanah N Polotsky; Matvey Brokhin; Gal Omry; Alex J Polotsky; R Michael Tuttle Journal: Clin Endocrinol (Oxf) Date: 2012-04 Impact factor: 3.478
Authors: Eva Maria Braun; Gunther Windisch; Gerhard Wolf; Lisa Hausleitner; Friedrich Anderhuber Journal: Surg Radiol Anat Date: 2006-12-05 Impact factor: 1.246
Authors: Aleksandra Popadich; Olga Levin; James C Lee; Stephanie Smooke-Praw; Kevin Ro; Maisam Fazel; Asit Arora; Neil S Tolley; Fausto Palazzo; Diana L Learoyd; Stan Sidhu; Leigh Delbridge; Mark Sywak; Michael W Yeh Journal: Surgery Date: 2011-12 Impact factor: 3.982
Authors: David T Hughes; Amanda M Laird; Barbra S Miller; Paul G Gauger; Gerard M Doherty Journal: Ann Surg Oncol Date: 2012-04-24 Impact factor: 5.344
Authors: F Christopher Holsinger; Uma Ramaswamy; Maria E Cabanillas; Juntian Lang; Heather Y Lin; Naifa L Busaidy; Elizabeth Grubbs; Sania Rahim; Erich M Sturgis; Jeffrey E Lee; Randal S Weber; Gary L Clayman; Eric M Rohren Journal: JAMA Otolaryngol Head Neck Surg Date: 2014-05 Impact factor: 6.223
Authors: Sang Gab Yoon; Jin Wook Yi; Chan-Yong Seong; Jong-Kyu Kim; Su-Jin Kim; Young Jun Chai; June Young Choi; Kyu Eun Lee Journal: Ann Surg Treat Res Date: 2017-02-24 Impact factor: 1.859
Authors: Ora Israel; O Pellet; L Biassoni; D De Palma; E Estrada-Lobato; G Gnanasegaran; T Kuwert; C la Fougère; G Mariani; S Massalha; D Paez; F Giammarile Journal: Eur J Nucl Med Mol Imaging Date: 2019-07-04 Impact factor: 9.236
Authors: Elizabeth J de Koster; Taban Sulaiman; Jaap F Hamming; Abbey Schepers; Marieke Snel; Floris H P van Velden; Lioe-Fee de Geus-Oei; Dennis Vriens Journal: Diagnostics (Basel) Date: 2021-03-19